Improving lymphatic function protects mice from experimental colitis

Chronic inflammatory bowel disease can be painful and debilitating. Both genetics and environment are thought to promote disease, but it is not fully understood how chronic IBD develops. Emerging evidence indicates that IBD is associated with an increase in lymphatic vasculature, which transports lymph throughput the body. It is not clear if these lymphatic vessels promote or improve IBD.

A new study in the Journal of Clinical Investigation indicates that improving lymphatic function relieves experimental IBD in mice. Silvio Danese and colleagues at Humanitas Clinical and Research Center gave mice a compound called VEGF-C that improves lymphatic function prior to the onset of experimental IBD. VEGF-C treatment prevented development of both chronic and acute IBD.

This study indicates that augmenting lymphatic function helps prevent and suggests that VEGF-C should be further tested for use in IBD.


Explore further

Exposure to inflammatory bowel disease drugs could increase leukemia risk

More information: VEGF-C–dependent stimulation of lymphatic function ameliorates experimental inflammatory bowel disease, J Clin Invest. DOI: 10.1172/JCI72189
Citation: Improving lymphatic function protects mice from experimental colitis (2014, August 8) retrieved 21 September 2019 from https://medicalxpress.com/news/2014-08-lymphatic-function-mice-experimental-colitis.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more